Our study discovered that TMEM59L expression was linked with neoantigens in only a limited number of cancers, such as COAD, COADREAD, GBM, UCEC, while no link was evident in other cancers (Figure 8E). This evidence concerns the gene TMEM59L and glioblastoma.